SPR Therapeutics

SPRINT PNS System

60-day percutaneous PNS

FDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso

–Data from 5,518 Patients were Critical to Achieving the Broader Indication– Cleveland, Ohio- October 19, 2021- SPR Therapeutics® has obtained clearance from the U.S. Food and Drug Administration …
Read moreFDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso
Category: Tag: , , , , , ,

SPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System

– Expanding U.S. Commercial Team Amid Record-Breaking Growth – Cleveland, Ohio- October 18, 2021- SPR Therapeutics, a private medical device company focused on providing patients with pain relief …
Read moreSPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System
Category: Tag: , , , , ,

For Physicians: How to Help Back Pain Patients When Choosing Between RFA and Short-Term PNS

When it comes to treating chronic back pain using a medial branch approach, short-term, or temporary, peripheral nerve stimulation (PNS) and radiofrequency ablation (RFA) commonly come up as options. …
Read moreFor Physicians: How to Help Back Pain Patients When Choosing Between RFA and Short-Term PNS
Category: Tag: , , , , , , ,